← Eichor
Condition: Laryngeal Carcinoma Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Laryngeal Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer
NA · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT07180901
Clinical Study of Curcumin in Preventing Postoperative Adhesion of Bilateral Vocal Cords
Phase 1/Phase 2 · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT05688488
Personalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The PRIMO Stud
Phase 3 · 9 location(s) · Radboud University Medical Center · NCT05333523
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279
Lymphocyte-Sparing And Radio-Immunotherapy in Head and Neck Carcinoma
Phase 3 · 8 location(s) · Centre Leon Berard · NCT06706401
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Ca
Phase 3 · 205 location(s) · Merus B.V. · NCT06525220
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S
Phase 2 · 225 location(s) · National Cancer Institute (NCI) · NCT05136196
Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-esca
Phase 2 · 1 location(s) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · NCT07209189
Aortic Laryngeal Rehabilitation Graft
NA · 1 location(s) · University Hospital, Strasbourg, France · NCT04650919
Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Docetaxel
Phase N/A · 1 location(s) · University of Erlangen-Nürnberg Medical School · NCT06947668
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
Phase 1 · 18 location(s) · National Cancer Institute (NCI) · NCT05172245
VoiceS: Voice Quality After Transoral CO2-Laser Surgery Versus Single Vocal Cord Irradiation for Larynx Cancer
NA · 4 location(s) · Olgun Elicin · NCT04057209
Compartmentalized Postoperative Radiotherapy in Head and Neck Cancer
Phase 2 · 3 location(s) · Olgun Elicin · NCT07058805
Neoadjuvant Chemoimmunotherapy Followed By Radiation Or Organ Preservation Surgery In Laryngeal/Hypopharyngeal Cancer
Phase 2 · 1 location(s) · Fudan University · NCT06039631
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Phase 2 · 1 location(s) · Christopher Wilke · NCT02128906
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
NA · 4 location(s) · Medical University of South Carolina · NCT05793151
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Phase N/A · 68 location(s) · Massive Bio, Inc. · NCT03452774
Intraoral Hypothermia Device for Preserving Taste During Radiation
EARLY_Phase 1 · 1 location(s) · Henry Ford Health System · NCT06579248
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03114462
Precision Medicine: MRI-Guided Stereotactic Ablative Radiotherapy (MRI-SABR) for Early-Stage Glottic Laryngeal Cancer
NA · 1 location(s) · Viktoras Rudzianskas · NCT07391345
Clinical Treatments in Specialized Diseases of Laryngeal Carcinoma (LC) and Hypopharyngeal Carcinoma (HPC)
Phase N/A · 1 location(s) · Eye & ENT Hospital of Fudan University · NCT04908696
High-Resolution PET-CT Imaging for Surgical Margin Visualization
NA · 1 location(s) · Vanderbilt-Ingram Cancer Center · NCT06915454
Telemedicine Follow-Up for Early Laryngeal Cancer: a Randomized Controlled Trial Comparing Care Close to Home Versus Sta
NA · 1 location(s) · University Medical Center Groningen · NCT06940505
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cance
Phase 2/Phase 3 · 16 location(s) · Cancer Research UK · NCT05768178
Use of SPY Imaging System to Minimize Fistulas After Hypopharyngeal Reconstruction
Phase 2 · 1 location(s) · Matthew Spector · NCT06831149
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
Phase 2 · 100 location(s) · National Cancer Institute (NCI) · NCT07195734
The Role of the Free/Pedunculated Flap in Total Laryngectomy After (Chemo-)Radiotherapy Failure for Laryngeal Carcinoma:
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT06287034
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Can
Phase N/A · 1 location(s) · University of Colorado, Denver · NCT00900419
RAPA-201 Therapy of Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Rapa Therapeutics LLC · NCT05144698
Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest
Phase 2 · 1 location(s) · Mayo Clinic · NCT06997068
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.